SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-077836
Filing Date
2024-07-03
Accepted
2024-07-03 17:18:10
Documents
1
Period of Report
2023-11-17

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2417696-5_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2417696-5_4seq1.xml 4 8983
  Complete submission text file 0001104659-24-077836.txt   10490
Mailing Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE, SUITE 225 MALVERN PA 19355 484-875-3192
Annovis Bio, Inc. (Issuer) CIK: 0001477845 (see all company filings)

IRS No.: 262540421 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 227 7TH AVENUE NE ST. PETERSBURG FL 33701
Business Address
White Mark K. (Reporting) CIK: 0001786183 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39202 | Film No.: 241100943